The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
Status:
Unknown status
Trial end date:
2018-12-22
Target enrollment:
Participant gender:
Summary
In this clinical cohort study, the investigators are going to observe the efficacy of
anti-coagulation and immune therapy in the treatment of recurrent pregnancy loss with a
prospective randomized controlled trial.